ArticlePediatrics2005
The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.
Article in Pediatrics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.Journal of child and adolescent psychopharmacology · 2009Trial
- History of Minor Consent Laws for Mental Health Treatment in the US.JAMA health forum · 2026Article
- Global research in schizophrenia and serotonin: a bibliometric analysis.Frontiers in psychiatry · 2024Review
- Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified.Frontiers in psychiatry · 2020Review
- Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.Psychiatric services (Washington, D.C.) · 2016Article
- Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS).PLoS medicine · 2016Review
- Antidepressants and suicide attempts in children.Pediatrics · 2014Observational
- Should we treat depression with drugs or psychological interventions? A reply to Ioannidis.Philosophy, ethics, and humanities in medicine : PEHM · 2011Article
- Intervention research with youths at elevated risk for suicide: meeting the ethical and regulatory challenges of informed consent and assent.Suicide & life-threatening behavior · 2008Article
- Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide.Statistics in medicine · 2008Article
- Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users.Statistics in medicine · 2008Article
- Management of treatment-resistant panic disorder.Psychiatry (Edgmont (Pa. : Township)) · 2007Article
- Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.The Journal of clinical psychiatryArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
On February 2, 2004, the Food and Drug Administration organized a joint meeting of the Neuro-Psychopharmacologic Advisory Committee and Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee to examine the occurrence of suicidality in clinical trials that investigate the use of the newer antidepressant drugs in pediatric patients. Committee members reconvened on September 13-14, 2004, and concluded that there was a causal link between the newer antidepressants and pediatric suicidality. This article provides a summary of the Food and Drug Administration deliberations for the pediatric clinician. We also provide research, regulation, education, and practice implications for care for children and adolescents who may be eligible for treatment with these medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.